Clinical Trial

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
To determine whether olanzapine or mirtazapine is more effective in preventing weight loss and appetite loss in cancer patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-12-10; most recent amendment 2024-09-09.
Trial Details
NCT Number NCT05170919
Lead Sponsor Englewood Hospital and Medical Center
Conditions Anorexia Nervosa with Significantly Low Body Weight
Enrollment 170 participants
Start Date 2022-01-20
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-19